Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Mariel Metcalfe
  • June 25, 2019
  • News

Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports

Research Partnership publishes new patient Living with Ankylosing Spondylitis & nr-axSpA EU & US 2019 reports

Living with Ankylosing Spondylitis (AS) & nr-AxSpA are reports based on quantitative studies conducted online in the 5EU and US. The AS 5EU report comprises of interviews with 385 patients in France, Germany, Italy, Spain and UK, while the AS US report is based on a study of 136 patients.  The Living with nr-AxSpA report comprises of interviews with a total of 78 patients in the 5EU and the US. All of the studies consist of 30-minute quantitative online interviews and for the AS studies 30 minute qualitative tele-depth interviews. The reports are available to purchase in the following formats: AS (5EU), AS (US) and nr-AxSpA (5EU & US).

read more »

  • Posted by Rachel Howard & Brett Gardiner
  • June 20, 2019
  • Events

ISPOR Annual Conference 2019

ISPOR Annual Conference 2019

Last month, Directors Brett Gardiner and Rachel Howard attended the ISPOR annual conference in New Orleans.

With over 4,000 delegates in attendance and a three-day program packed with panel presentations, poster sessions, educational symposia and workshops, this is the leading global conference for health economics and outcomes research.

read more »

  • Posted by Pei Li Teh
  • June 11, 2019
  • Articles

Fast and furious: What will the fast tracking of approvals for key drugs mean for China's pharma market?

Fast and furious: What will the fast tracking of approvals for key drugs mean for China's pharma market?

China has long been a magnet for pharmaceutical multinationals looking to offset flattening growth in established markets

It offers rapid economic development, a population of around 1.4 billion with limited access to cutting-edge medicine, and changing lifestyles that have raised health expectations. Expanded access to state-funded healthcare, population aging and a growing burden of chronic disease are creating new opportunities for innovative drugs alongside low-cost generics. 

read more »

  • Posted by Julie Denny
  • June 6, 2019
  • News

Andrew Stokes promoted to Senior Director

Andrew Stokes promoted to Senior Director

We are delighted to announce the promotion of Andrew Stokes to Senior Director in our UK headquarters.

Andrew has 19 years of healthcare market research experience and joined Research Partnership as a graduate in 2000. Over the years he has made a significant contribution to the success of the company, both from a research perspective and in terms of providing management and leadership support.
 

read more »

  • Posted by Pei Li Teh
  • June 3, 2019
  • News

Singapore team’s annual volunteer day

Singapore team’s annual volunteer day

This year, volunteers from our Singapore office are collaborating with local charity, Willing Hearts.

Willing Hearts operates a soup kitchen that prepares, cooks and distributes 5,000 meals 365 days a year. Beneficiaries include the elderly, the disabled, low-income families, and migrant workers in Singapore.On 28th June, volunteers will be starting at the crack of dawn (5am!) as soon as the kitchen doors open, with everyone assigned to various stations throughout the day. 

read more »